X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3923) 3923
Publication (338) 338
Book Review (69) 69
Book Chapter (6) 6
Magazine Article (3) 3
Dissertation (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3118) 3118
oncology (2833) 2833
index medicus (2358) 2358
chemotherapy (1963) 1963
female (1601) 1601
male (1528) 1528
aged (1445) 1445
middle aged (1435) 1435
cancer (1422) 1422
antineoplastic combined chemotherapy protocols - therapeutic use (1404) 1404
colorectal cancer (1335) 1335
colorectal neoplasms - drug therapy (1199) 1199
fluorouracil (1123) 1123
adult (1120) 1120
1st-line treatment (1106) 1106
treatment outcome (1028) 1028
oxaliplatin (1013) 1013
leucovorin (956) 956
colorectal neoplasms - pathology (891) 891
metastasis (818) 818
bevacizumab (768) 768
care and treatment (747) 747
fluorouracil - administration & dosage (725) 725
capecitabine (674) 674
irinotecan (672) 672
phase-iii trial (658) 658
antineoplastic combined chemotherapy protocols - adverse effects (640) 640
metastatic colorectal-cancer (619) 619
antineoplastic agents - therapeutic use (601) 601
5-fluorouracil (589) 589
medicine & public health (578) 578
plus irinotecan (571) 571
disease-free survival (560) 560
cetuximab (557) 557
pharmacology & pharmacy (553) 553
deoxycytidine - analogs & derivatives (546) 546
neoplasm metastasis (541) 541
research (541) 541
aged, 80 and over (535) 535
fluorouracil plus leucovorin (521) 521
camptothecin - analogs & derivatives (518) 518
prognosis (498) 498
therapy (496) 496
survival (489) 489
drug therapy (488) 488
trial (484) 484
phase-ii trial (466) 466
neoplasm staging (444) 444
leucovorin - administration & dosage (441) 441
randomized-trial (437) 437
organoplatinum compounds - administration & dosage (427) 427
surgery (427) 427
antineoplastic combined chemotherapy protocols - administration & dosage (417) 417
clinical trials (414) 414
survival rate (401) 401
camptothecin - administration & dosage (388) 388
fluorouracil - analogs & derivatives (385) 385
deoxycytidine - administration & dosage (383) 383
analysis (381) 381
combination (379) 379
gastroenterology & hepatology (372) 372
survival analysis (369) 369
stomach neoplasms - drug therapy (365) 365
open-label (361) 361
health aspects (359) 359
retrospective studies (354) 354
phase-iii (350) 350
carcinoma (346) 346
cancer therapies (338) 338
hematology, oncology and palliative medicine (338) 338
cancer research (334) 334
adenocarcinoma - drug therapy (330) 330
fluorouracil - therapeutic use (324) 324
colorectal neoplasms - mortality (320) 320
liver neoplasms - secondary (319) 319
cisplatin (318) 318
tumors (317) 317
randomized phase-iii (313) 313
folinic acid (307) 307
antineoplastic agents (306) 306
growth-factor receptor (302) 302
fluorouracil - adverse effects (299) 299
colorectal neoplasms - genetics (296) 296
antibodies, monoclonal - therapeutic use (295) 295
antimitotic agents (289) 289
colon-cancer (286) 286
mutation (285) 285
patients (284) 284
antibodies, monoclonal, humanized (282) 282
gastric cancer (281) 281
chemotherapy, adjuvant (280) 280
cetuximab plus irinotecan (278) 278
metastatic colorectal cancer (277) 277
drug administration schedule (276) 276
oral capecitabine (276) 276
animals (271) 271
pancreatic cancer (265) 265
clinical trials as topic (262) 262
plus (262) 262
adenocarcinoma (259) 259
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3850) 3850
German (35) 35
French (29) 29
Italian (5) 5
Japanese (3) 3
Polish (2) 2
Chinese (1) 1
Korean (1) 1
Serbian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1245 - 1253
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2005, Volume 16, Issue 5, pp. 762 - 766
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 15, pp. 1755 - 1762
Journal Article
CANCER, ISSN 0008-543X, 04/2011, Volume 117, Issue 7, pp. 1422 - 1428
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 31, pp. 3520 - 3526
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4706 - 4713
Panitumumab is a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that improves progression-free survival (PFS) in... 
SURVIVAL | 1ST-LINE TREATMENT | CONTROLLED-TRIAL | SUPPORTIVE CARE | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | KRAS | OXALIPLATIN | FAILURE | CHEMOTHERAPY | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Chemotherapy, Adjuvant | Colorectal Neoplasms - metabolism | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2007, Volume 25, Issue 12, pp. 1539 - 1544
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4697 - 4705
Purpose Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that improves progression-free survival (PFS), is approved... 
KRAS MUTATIONS | MCRC | ONCOLOGY | STATISTICS | CETUXIMAB PLUS IRINOTECAN | CHEMOTHERAPY CT | OPEN-LABEL | COMBINATION | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Colorectal Neoplasms - metabolism | Colorectal Neoplasms - mortality | Drug Administration Schedule | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2005, Volume 23, Issue 15, pp. 3502 - 3508
Purpose In a phase III trial, combining bevacizumab (BV)-a recombinant, humanized, monoclonal antibody targeting vascular endothelial growth factor-with... 
THERAPY | SOLID TUMORS | ONCOLOGY | RANDOMIZED-TRIAL | IRINOTECAN | ANTIBODY | TOXICITY | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | PLUS FLUOROURACIL
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9617, pp. 1007 - 1016
Summary Background Surgical resection alone is regarded as the standard of care for patients with liver metastases from colorectal cancer, but relapse is... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | COLON-CANCER | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | HEPATIC ARTERIAL INFUSION | PLUS IRINOTECAN | OXALIPLATIN | SURGICAL RESECTION | FOLINIC ACID | FLUOROURACIL | Humans | Middle Aged | Liver Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Liver Neoplasms - surgery | Male | Combined Modality Therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Perioperative Care - methods | Adult | Female | Aged | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Chemotherapy | Care and treatment | Colorectal cancer | Leucovorin | Dosage and administration | Excision (Surgery) | Metastasis | Methods | Fluorouracil | Cancer | Heart failure | Hospitals | Medical treatment | Mortality | Liver | Risk | Histology | Angina pectoris | Cancer surgery | Index Medicus | Abridged Index Medicus | Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use | Medical and Health Sciences | Medicin och hälsovetenskap | Colorectal Neoplasms/pathology | Liver Neoplasms/drug therapy/secondary/surgery | MEDICINE | MEDICIN | Organoplatinum Compounds/administration & dosage | Perioperative Care/methods | Fluorouracil/administration & dosage
Journal Article